Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

Pandemic positives--a seroepidemiology consortium has formed and significant A(H1N1)pdm09 research continues to flow and demand journal pages.

Hampson AW.

Influenza Other Respir Viruses. 2013 May;7(3):227. doi: 10.1111/irv.12114. No abstract available.

2.

The 'novel' influenza A(H1N1) enigma: is it a pandemic, how should we respond, what should we call it?

Hampson AW.

Influenza Other Respir Viruses. 2009 Jul;3(4):119-20. doi: 10.1111/j.1750-2659.2009.00092.x. No abstract available.

3.

Special Edition: Editorial

Hampson AW, Wood J.

Influenza Other Respir Viruses. 2008 Nov;2(6):191-2. doi: 10.1111/j.1750-2659.2008.00065.x. No abstract available.

4.

Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses.

Russell CA, Jones TC, Barr IG, Cox NJ, Garten RJ, Gregory V, Gust ID, Hampson AW, Hay AJ, Hurt AC, de Jong JC, Kelso A, Klimov AI, Kageyama T, Komadina N, Lapedes AS, Lin YP, Mosterin A, Obuchi M, Odagiri T, Osterhaus AD, Rimmelzwaan GF, Shaw MW, Skepner E, Stohr K, Tashiro M, Fouchier RA, Smith DJ.

Vaccine. 2008 Sep 12;26 Suppl 4:D31-4. Review.

PMID:
19230156
5.

Sustained attention in children with two etiologies of early hydrocephalus.

Swartwout MD, Cirino PT, Hampson AW, Fletcher JM, Brandt ME, Dennis M.

Neuropsychology. 2008 Nov;22(6):765-75. doi: 10.1037/a0013373.

6.

Characteristics of a spina bifida population including North American Caucasian and Hispanic individuals.

Au KS, Tran PX, Tsai CC, O'Byrne MR, Lin JI, Morrison AC, Hampson AW, Cirino P, Fletcher JM, Ostermaier KK, Tyerman GH, Doebel S, Northrup H.

Birth Defects Res A Clin Mol Teratol. 2008 Oct;82(10):692-700. doi: 10.1002/bdra.20499.

8.

The global circulation of seasonal influenza A (H3N2) viruses.

Russell CA, Jones TC, Barr IG, Cox NJ, Garten RJ, Gregory V, Gust ID, Hampson AW, Hay AJ, Hurt AC, de Jong JC, Kelso A, Klimov AI, Kageyama T, Komadina N, Lapedes AS, Lin YP, Mosterin A, Obuchi M, Odagiri T, Osterhaus AD, Rimmelzwaan GF, Shaw MW, Skepner E, Stohr K, Tashiro M, Fouchier RA, Smith DJ.

Science. 2008 Apr 18;320(5874):340-6. doi: 10.1126/science.1154137.

9.

Influenza and Other Respiratory Viruses: third issue status update.

Hampson AW.

Influenza Other Respir Viruses. 2007 May;1(3):81. doi: 10.1111/j.1750-2659.2007.00021.x. No abstract available.

10.

The establishment of the International Society for Influenza and other Respiratory Viruses.

Hampson AW.

Influenza Other Respir Viruses. 2007 Jan;1(1):3. doi: 10.1111/j.1750-2659.2006.00002.x. No abstract available.

11.

The influenza viruses.

Hampson AW, Mackenzie JS.

Med J Aust. 2006 Nov 20;185(10 Suppl):S39-43. Review.

PMID:
17115950
12.

Avian influenza: a pandemic waiting in the wings?

Hampson AW.

Emerg Med Australas. 2006 Oct-Dec;18(5-6):420-9. Review.

PMID:
17083630
13.

Outbreak of influenza amongst residential school students in Malaysia.

Ayob A, Selviendran N, Hampson AW, Barr IG, Kumarasamy V, Chua KB.

Med J Malaysia. 2006 Jun;61(2):168-72.

14.

Identification of genetic diversity by cultivating influenza A(H3N2) virus in vitro in the presence of post-infection sera from small children.

Haaheim LR, Tomasov CC, Barr IG, Hampson AW, Komadina N.

Vaccine. 2006 Nov 10;24(44-46):6708-11. Epub 2006 Jun 12.

PMID:
16844271
16.

Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use.

Monto AS, McKimm-Breschkin JL, Macken C, Hampson AW, Hay A, Klimov A, Tashiro M, Webster RG, Aymard M, Hayden FG, Zambon M.

Antimicrob Agents Chemother. 2006 Jul;50(7):2395-402.

17.

Ferrets and the challenges of H5N1 vaccine formulation.

Hampson AW.

J Infect Dis. 2006 Jul 15;194(2):143-5. Epub 2006 Jun 9. No abstract available.

PMID:
16779718
18.

Isolation of avian influenza viruses from two different transhemispheric migratory shorebird species in Australia.

Hurt AC, Hansbro PM, Selleck P, Olsen B, Minton C, Hampson AW, Barr IG.

Arch Virol. 2006 Nov;151(11):2301-9. Epub 2006 May 26.

PMID:
16732420
19.

Neuraminidase inhibitor-resistant and -sensitive influenza B viruses isolated from an untreated human patient.

Hurt AC, Iannello P, Jachno K, Komadina N, Hampson AW, Barr IG, McKimm-Breschkin JL.

Antimicrob Agents Chemother. 2006 May;50(5):1872-4.

20.

Reactogenicity and immunogenicity of an inactivated influenza vaccine administered by intramuscular or subcutaneous injection in elderly adults.

Cook IF, Barr I, Hartel G, Pond D, Hampson AW.

Vaccine. 2006 Mar 20;24(13):2395-402. Epub 2005 Dec 13.

PMID:
16406171
21.

A comparison of a rapid test for influenza with laboratory-based diagnosis in a paediatric population.

Alexander R, Hurt AC, Lamb D, Wong FY, Hampson AW, Barr IG.

Commun Dis Intell Q Rep. 2005;29(3):272-6.

22.

An influenza A(H3) reassortant was epidemic in Australia and New Zealand in 2003.

Barr IG, Komadina N, Hurt AC, Iannello P, Tomasov C, Shaw R, Durrant C, Sjogren H, Hampson AW.

J Med Virol. 2005 Jul;76(3):391-7.

PMID:
15902711
23.

Concurrent summer influenza and pertussis outbreaks in a nursing home in Sydney, Australia.

Ferson MJ, Morgan K, Robertson PW, Hampson AW, Carter I, Rawlinson WD.

Infect Control Hosp Epidemiol. 2004 Nov;25(11):962-6.

PMID:
15566031
24.

Surveillance for neuraminidase inhibitor resistance in human influenza viruses from Australia.

Hurt AC, Barr IG, Durrant CJ, Shaw RP, Sjogren HM, Hampson AW.

Commun Dis Intell Q Rep. 2003;27(4):542-7.

25.

In vitro generation and characterisation of an influenza B variant with reduced sensitivity to neuraminidase inhibitors.

Cheam AL, Barr IG, Hampson AW, Mosse J, Hurt AC.

Antiviral Res. 2004 Sep;63(3):177-81.

PMID:
15451185
26.

Avian influenza and planning for pandemics.

Isaacs D, Dwyer DE, Hampson AW.

Med J Aust. 2004 Jul 19;181(2):62-3. No abstract available.

PMID:
15257636
27.

Influenza outbreaks in aged-care facilities: staff vaccination and the emerging use of antiviral therapy.

Guy RJ, Di Natale R, Kelly HA, Lambert SB, Tobin S, Robinson PM, Tallis G, Hampson AW.

Med J Aust. 2004 Jun 21;180(12):640-2. No abstract available.

PMID:
15200364
28.

Identification of a human influenza type B strain with reduced sensitivity to neuraminidase inhibitor drugs.

Hurt AC, McKimm-Breschkin JL, McDonald M, Barr IG, Komadina N, Hampson AW.

Virus Res. 2004 Jul;103(1-2):205-11.

PMID:
15163511
29.

A novel means of identifying the neuraminidase type of currently circulating human A(H1) influenza viruses.

Hurt AC, Barr IG, Komadina N, Hampson AW.

Virus Res. 2004 Jul;103(1-2):79-83.

PMID:
15163493
30.
31.

Reassortants in recent human influenza A and B isolates from South East Asia and Oceania.

Barr IG, Komadina N, Hurt A, Shaw R, Durrant C, Iannello P, Tomasov C, Sjogren H, Hampson AW.

Virus Res. 2003 Dec;98(1):35-44.

PMID:
14609628
32.

The epidemiology and clinical impact of pandemic influenza.

Nguyen-Van-Tam JS, Hampson AW.

Vaccine. 2003 May 1;21(16):1762-8.

PMID:
12686091
33.

Pandemic influenza: history, extent of the problem and approaches to control.

Hampson AW.

Dev Biol (Basel). 2002;110:115-23. No abstract available.

PMID:
12477314
34.

Planning for the next pandemic of influenza.

Gust ID, Hampson AW, Lavanchy D.

Rev Med Virol. 2001 Jan-Feb;11(1):59-70. Review.

PMID:
11241802
35.

Utilization of professional supportive care services by women with breast cancer.

Gray RE, Goel V, Fitch MI, Franssen E, Chart P, Greenberg M, Bakker D, Labrecque M, Hollowaty E, Godel R, Hampson AW.

Breast Cancer Res Treat. 2000 Dec;64(3):253-8.

PMID:
11200775
36.

Low incidence of rimantadine resistance in field isolates of influenza A viruses.

Ziegler T, Hemphill ML, Ziegler ML, Perez-Oronoz G, Klimov AI, Hampson AW, Regnery HL, Cox NJ.

J Infect Dis. 1999 Oct;180(4):935-9.

PMID:
10479115
37.

Influenza surveillance in Australia.

Hampson AW.

Vaccine. 1999 Jul 30;17 Suppl 1:S113-4. No abstract available.

PMID:
10471195
38.

Vaccination of the older adult: the Australian experience.

Hampson AW.

Vaccine. 1999 Jul 30;17 Suppl 1:S63-6. No abstract available.

PMID:
10471184
39.

Epidemiological data on influenza in Asian countries.

Hampson AW.

Vaccine. 1999 Jul 30;17 Suppl 1:S19-23. No abstract available.

PMID:
10471175
40.

Use of oligonucleotide probes for selecting potential high-yielding influenza reassortants.

Sahasrabudhe A, Ekkel S, Hampson AW, McKimm-Breschkin JL.

J Virol Methods. 1997 Nov;68(2):139-45.

PMID:
9389403
41.

Influenza vaccination in 22 developed countries: an update to 1995.

Fedson DS, Hirota Y, Shin HK, Cambillard PE, Kiely J, Ambrosch F, Hannoun C, Leese J, Sprenger MJ, Hampson AW, Bro-Jørgensen K, Ahlbom AM, Nøkleby H, Valle M, Olafsson O, Salmerón F, Cloetta J, Rebelo de Andrade H, Snacken R, Donatelli I, Jennings LC, Strikas RA.

Vaccine. 1997 Oct;15(14):1506-11.

PMID:
9330460
42.

Surveillance for pandemic influenza.

Hampson AW.

J Infect Dis. 1997 Aug;176 Suppl 1:S8-13.

PMID:
9240687
43.

Influenza vaccination: cost-effective health care for the older adult?

Hampson AW, Irving LB.

J Qual Clin Pract. 1997 Mar;17(1):3-11.

PMID:
9107599
44.

Options for the control of influenza III. Cairns, North Queensland, Australia (4-9 May 1996).

Ada GL, Tannock GA, Hampson AW.

Vaccine. 1997 Feb;15(3):245-7. No abstract available.

PMID:
9139481
45.

Improving influenza vaccine coverage. Where we are and where we should be heading.

Carnie JA, Hampson AW.

Aust Fam Physician. 1996 Mar;25(3):269-71. No abstract available.

PMID:
8867177
46.

Influenza vaccination in 18 developed countries, 1980-1992.

Fedson DS, Hannoun C, Leese J, Sprenger MJ, Hampson AW, Bro-Jørgensen K, Ahlbom AM, Nøkelby H, Valle M, Olafsson O, et al.

Vaccine. 1995 May;13(7):623-7.

PMID:
7668032
47.

Measurement of IgM responses to a subunit influenza A vaccine by sucrose-gradient centrifugation and membrane-filtration enzyme immunoassays.

Tannock GA, Bryce DA, Barnett GR, Hampson AW, Hensley MJ, Saunders NA.

Biologicals. 1991 Jan;19(1):17-21.

PMID:
2049172
48.

Direct role of viral hemagglutinin in B-cell mitogenesis by influenza viruses.

Poumbourios P, Anders EM, Scalzo AA, White DO, Hampson AW, Jackson DC.

J Virol. 1987 Jan;61(1):214-7.

49.

A simple endpoint dilution method for evaluating serum used for cell culture.

Jiang SD, Hampson AW.

J Biol Stand. 1985 Oct;13(4):303-8.

PMID:
4055806
50.

Enzyme immunoassay for antibodies to membrane associated antigen of varicella zoster virus.

Cox JC, Moloney MB, Herrington RW, Hampson AW, Hurrell JG.

J Virol Methods. 1984 Feb;8(1-2):137-45.

PMID:
6323506

Supplemental Content

Loading ...
Support Center